Group 1 | Group 2 | Group 3 | Group 4 | |
---|---|---|---|---|
Without CKD and without depression | Without CKD and with depression | With CKD and without depression | With CKD and with depression | |
Number of Participants | 18,334 | 1695 | 3928 | 455 |
Follow-up (person-years) | 106,846 | 9565 | 21,100 | 2125 |
All-cause mortality | ||||
Events (n) | 785 | 79 | 809 | 110 |
Mortality rate (95% CI)# | 5.2 (4.7–5.8) | 6.9 (5.2–8.6) | 32.8 (30.0–35.7) | 46.6 (36.3–56.9) |
Hazard ratio (95% CI) | ||||
Model 0 | 1.00 (reference) | 1.33 (1.00–1.78) | 6.36 (5.61–7.22) | 9.26 (7.19–11.93) |
Model 1 | 1.00 (reference) | 1.50 (1.14–1.98) | 2.16 (1.88–2.48) | 4.38 (3.45–5.56) † |
Model 2 | 1.00 (reference) | 1.46 (1.10–1.93) | 1.84 (1.59–2.12) | 3.46 (2.63–4.54) † |
Model 3 | 1.00 (reference) | 1.43 (1.06–1.94) | 1.86 (1.52–2.27) | 3.24 (2.37–4.42) † |
CVD mortality | ||||
Events (n) | 125 | 15 | 172 | 26 |
Mortality rate (95% CI) | 0.8 (0.6 to 1.0) | 1.5 (0.6–2.5) | 6.6 (5.3–7.9) | 10.3 (5.4–15.2) |
Hazard ratio (95% CI) | ||||
Model 0 | 1.00 (reference) | 1.96 (0.97–3.95) | 8.53 (6.38–11.40) | 13.5 (7.88–23.00) |
Model 1 | 1.00 (reference) | 2.51 (1.25–5.04) | 2.33 (1.71–3.19) | 5.72 (3.39–9.67) ‡ |
Model 2 | 1.00 (reference) | 2.35 (1.15–4.78) | 1.87 (1.36–2.58) | 3.91 (2.21–6.93) ‡ |
Model 3 | 1.00 (reference) | 2.33 (1.12–4.83) | 1.89 (1.31–2.72) | 3.43 (1.82–6.45) ‡ |